These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30561565)

  • 21. Coronary Artery Aneurysm After Bioresorbable Vascular Scaffold Implantation With Post-Dilation: Is Less More?
    Meincke F; Reinholz C; Spangenberg T; Wienemann H; Arjomand A; Kreidel F; Kuck KH; Ghanem A
    JACC Cardiovasc Interv; 2017 Jan; 10(1):96-97. PubMed ID: 28017314
    [No Abstract]   [Full Text] [Related]  

  • 22. Treading the risky ground of coronary bifurcation lesion revascularization, the "biodegradable strategy" may represent the lifeline.
    Piraino D; Buccheri D; Andolina G
    Int J Cardiol; 2016 Oct; 221():577-80. PubMed ID: 27420582
    [No Abstract]   [Full Text] [Related]  

  • 23. 1-year follow-up optical coherence tomography of a "hybrid" neocarina after T-stenting with small protrusion technique using a bioresorbable vascular scaffold and a metallic stent.
    Naganuma T; Panoulas VF; Latib A; Kawamoto H; Sato K; Miyazaki T; Colombo A
    JACC Cardiovasc Interv; 2015 May; 8(6):e101-e103. PubMed ID: 25912406
    [No Abstract]   [Full Text] [Related]  

  • 24. Vascular response and healing profile of everolimus-eluting bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: A one-year optical coherence tomography analysis from the GHOST-CTO registry.
    La Manna A; Miccichè E; D'Agosta G; Tensol Rodrigues Pereira G; Attizzani GF; Capranzano P; Capodanno D; Tamburino C
    Int J Cardiol; 2018 Feb; 253():45-49. PubMed ID: 29137819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized comparison of sirolimus eluting, and biolimus eluting bioresorbable polymer stents: the SORT-OUT VII optical coherence tomography study.
    Andreasen LN; Holm NR; Balleby IR; Krusell LR; Maeng M; Jakobsen L; Veien KT; Hansen KN; Kristensen SD; Hjort J; Kaltoft A; Dijkstra J; Terkelsen CJ; Lassen JF; Madsen M; Bøtker HE; Jensen LO; Christiansen EH
    Eur Heart J Cardiovasc Imaging; 2018 Mar; 19(3):329-338. PubMed ID: 28369332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optical coherence tomography follow-up after bioresorbable in metallic and metallic in bioresorbable stenting: tackling in-stent restenosis in the era of bioresorbable vascular scaffolds.
    Frangieh AH; Templin C; Binder RK
    Eur Heart J; 2015 Aug; 36(32):2183. PubMed ID: 26040803
    [No Abstract]   [Full Text] [Related]  

  • 27. Managing bioabsorbable vascular scaffold failure: combined scaffold restenosis and late-acquired coronary aneurysm treated with self-expandable stent.
    La Manna A; Mangiameli A; Capodanno D; Longo G; Sgroi C; Tamburino C
    Can J Cardiol; 2015 May; 31(5):691.e1-3. PubMed ID: 25936494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disruption of bioresorbable vascular scaffold struts due to loss of radial integrity: insights from optical coherence tomography.
    Ramalho AR; Silva Marques J; Mariano Pêgo G
    Int J Cardiovasc Imaging; 2017 Mar; 33(3):311-312. PubMed ID: 27832420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The buddy balloon technique to release a sticky ABSORB bioresorbable vascular scaffold balloon post-scaffolding.
    Yew KL
    Int J Cardiol; 2016 Mar; 207():1-2. PubMed ID: 26784563
    [No Abstract]   [Full Text] [Related]  

  • 30. Hybrid Strategy for Long Diffuse Coronary Lesion.
    Basavarajaiah S; Qadir M
    JACC Cardiovasc Interv; 2015 Sep; 8(11):1518-1521. PubMed ID: 26298227
    [No Abstract]   [Full Text] [Related]  

  • 31. First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study.
    Ormiston JA; Serruys PW; Onuma Y; van Geuns RJ; de Bruyne B; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Hebert KM; Rapoza R; Garcia-Garcia HM
    Circ Cardiovasc Interv; 2012 Oct; 5(5):620-32. PubMed ID: 23048057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three-month evaluation of strut healing using a novel optical coherence tomography analytical method following bioresorbable polymer everolimus-eluting stent implantation in humans: the TIMELESS study.
    Vesga B; Hernandez H; Moncada M; Gasior P; Higuera S; Dager A; Arana C; Delgado JA; Généreux P; Maehara A; Granada JF
    Coron Artery Dis; 2017 Mar; 28(2):126-134. PubMed ID: 27879518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.
    Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L
    Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delivery of a bioresorbable vascular scaffold to complex lesions.
    Meincke F; Kuck KH; Bergmann MW
    Catheter Cardiovasc Interv; 2014 Nov; 84(5):774-8. PubMed ID: 23907893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optical coherence tomography (OCT) of overlapping bioresorbable scaffolds: from benchwork to clinical application.
    Farooq V; Onuma Y; Radu M; Okamura T; Gomez-Lara J; Brugaletta S; Gogas BD; van Geuns RJ; Regar E; Schultz C; Windecker S; Lefèvre T; Brueren BR; Powers J; Perkins LL; Rapoza RJ; Virmani R; García-García HM; Serruys PW
    EuroIntervention; 2011 Jul; 7(3):386-99. PubMed ID: 21729842
    [No Abstract]   [Full Text] [Related]  

  • 37. Bifurcation lesions: Bioresorbable vascular scaffold and drug coated balloon, an efficacy association. Lessons from optimal coherence tomography.
    Piraino D; Carella M; Buccheri D; Andolina G
    Int J Cardiol; 2016 Jun; 212():92-3. PubMed ID: 27038711
    [No Abstract]   [Full Text] [Related]  

  • 38. Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow-up.
    Gomez-Lara J; Brugaletta S; Farooq V; van Geuns RJ; De Bruyne B; Windecker S; McClean D; Thuesen L; Dudek D; Koolen J; Whitbourn R; Smits PC; Chevalier B; Morel MA; Dorange C; Veldhof S; Rapoza R; Garcia-Garcia HM; Ormiston JA; Serruys PW
    JACC Cardiovasc Interv; 2011 Jul; 4(7):789-99. PubMed ID: 21777888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 'Full polymeric jacket' with bioresorbable vascular scaffolds in a diabetic patient affected by multivessel coronary disease: 1-year optical coherence tomography follow-up.
    Tarantini G; D'Amico G; Isabella G
    J Cardiovasc Med (Hagerstown); 2016 Dec; 17 Suppl 2():e105-e106. PubMed ID: 26090914
    [No Abstract]   [Full Text] [Related]  

  • 40. Optical Coherence Tomography Image of Coronary Spasm in a Bioresorbable Vascular Scaffold.
    Roa-Garrido J; Gomez-Menchero AE; El Amrawy AM; Cardenal-Piris R; Camacho-Freire S; Diaz-Fernandez JF
    Can J Cardiol; 2018 Mar; 34(3):343.e9-343.e10. PubMed ID: 29395707
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.